Introduction
The concept of antisense technology as drugs is immediate: the use of a complementary sequence to the mRNA, following the hybridization rules of Watson and Crick, can inhibit its expression then induce a stop in the transfer of the information from the DNA to the protein synthesis [1, 2] . Recently, the antisense technology has been combined with nanosensing feature, potentially able to provide real time monitoring of intracellular events [3] , merging the antisense drug property with the optical switch capability. Oligonucleotide optical switches are suitable molecules capable of turning on or modifying their light emission on molecular interaction with well-defined molecular targets. The use of an antisense oligonucleotide optical switch, able to generate a fluorescent signal when it hybridizes with the target mRNA, may represent an innovative strategy that conjugates the ability of sensing specific mRNA with the pharmacological silencing activity preventing the overexpression of proteins associated to pathologic conditions. Among these types of antisense oligonucleotide, molecular beacons (MBs) are very promising tools to optically monitor their interaction with the target molecule. They are formed by oligonucleotidic sequences labeled at the two side ends, with a fluorophore F A on one side and either a quencher Q or a second fluorophore F B on the other side, with the sequence properly designed so as to form a hairpin structure (stem-loop) when the complementary sequence is not present (Figure 1 ). In this condition, in the absence of the complementary target, the two labels are only a few angstroms separated and the fluorophore F A , if excited when the MB structure is closed, does not exhibit fluorescence but transfer the absorbed energy to the second label (fluorescence resonance energy transfer). No emitted light -if the second label is a quencher -or fluorescence at a longer wavelength than that one of the F A fluorescence -if the second label is a second fluorophore -is observed. In the presence of the target, the MB opens and the fluorophore F A is no more so close to the second label as to consent the energy transfer to the second label, and fluorescence at its emission wavelength is observed.
The use of carriers for the intracellular drug delivery or for the transportation of drugs in target cells, difficult to get in normal conditions, is a well-known strategy and the use of traditional delivery structures, more or less complex, such as liposomes, viruses antibodies, micelles, is the applied strategy [4] . With the advent of new nanosized materials, fascinating possibilities in the transport within the cells are appeared. The development of efficient methodology for the chemical modification has led to the preparation of functionalized nanoparticles [5, 6] on which a large variety of active molecules can be immobilized (e.g. peptides, proteins, oligonucleotidic chains and other therapeutic agents). An important aspect is the fact that the modified nanostructures have been shown to be able to cross the cellular membranes under well-controlled conditions with suitable mechanisms [7] .
In the present paper, we describe the design, implementation and characterization of complex nanostructures for intracellular survivin mRNA monitoring constituted by a molecular beacon, adsorbed on polymethylmethacrylate (PMMA) fluorescent nanoparticles (NPs). The mRNA specific for survivin has been chosen as target, being survivin a multifunctional protein that plays a role in cancer development and progression [8] and highly overexpressed in cancer cells.
Materials and methods
PMMA nanoparticles were synthesized at ISOF-CNR by emulsion polymerization and they were constituted by a core of PMMA surrounded by a shell bearing cationic quaternary ammonium (498 μmol/g) and -NH 2 (208 μmol/g) groups. The same nanoparticles were also functionalized, during the synthesis, with fluoresceine.
The survivin molecular beacon was purchased from IBA (Gottingen, Germany) with the following sequence [9] : 5'-(ATTO647N)CGACGGAGAAAGGGCTGCCACGXCG(BBQ)-3' X=C6-dT Thio. The underlined sequence represents the specific sequence for survivin mRNA. Atto 647N (λ abs 644 nm, λ em 669 nm) and Blackberry Quencher 650 (λ max ~ 650 nm, useful absorbance between 550 and 750 nm) were used as fluorophore/quencher pair. The MB complementary oligonucleotide (target 5'-CCCCTGCCTGGCAGCCCTTTCTCAAGGACC-3') and a non-specific sequence (random, 5'-ATCGGTGCGCTTGTCG-3') were purchased from MWG Biotech (Milan, Italy). RPMI1640 was purchased from Invitrogen.
Fluorescence measurements were carried out in a cuvette using, for excitation, a PicoQuant (LDH-P-C-635B) laser diode emitting at 635 nm filtered with a bandpass interference filter (ThorLabs FL635-10) at 635. An optical fibre (diameter 200 μm) oriented at 90° with respect to the direction of the excitation beam and with a GRIN lens on its tip was used to collect the fluorescent collimated signal and to send it to an Andor Shamrock 303 spectrograph. Cell images were obtained by a confocal microscope Biorad RadiancePlus and the Z stack images were analysed with ImageJ software with MEDNUC or 3D Volume Viewer plugins.
Results and discussions

Molecular beacon in solution
The molecular beacon targeting survivin mRNA was firstly characterized in solution, by evaluating its capability of binding the complementary sequence. A solution of 100 nm of MB in buffer (Tris 10 mM, MgCl 2 10 mM, pH 8) was exposed to different concentrations of the target from 0 to 1000 nM. Fluorescence measurements were conducted after 1, 3 and 5 h of incubation of the MB with the different solutions of target and very little variability was observed.
The calibration curves in Figure 2a shows the correct MB working with the increase of the fluorescence following an increase in the target concentration. Moreover, the MBs resulted to be specific for the target since the signal in presence of the non-specific sequence (100 nM) was equal to the one with only buffer.
The functionality and specificity of the MB were also examined in living cells by experiments performed on the human melanoma A375 cell line and using human monocytes as negative control. The 
Molecular beacon adsorbed onto nanoparticles in cells
The effects of different concentrations of PMMA nanoparticles on the adenocarcinomic human alveolar basal epithelial cells (A549) viability were analyzed by WST-1 assay, a colorimetric test that evaluates the mitochondrial enzymatic activity of the cells as index of cell viability. The results, expressed as % of cell viability vs an untreated control, showed a not toxic profile of activity of the PMMA nanoparticles up to 25 μg/mL (data not shown). On the basis of these results and in order to guarantee the visualization of suitable fluorescent signals, the concentration 10 μg/mL was chosen for the localization studies realized by confocal microscopy. In this phase, the experimental conditions have been optimized considering to use RPMI1640 supplemented with 10% FBS and a time of exposure of 1 h and 30 minutes which was the minimum time of treatment to which it was possible to state with certainty the intracellular localization of the nanoparticles.
MB-adsorbed onto NPs was also tested on the A549 cells in terms of internalization. These experiments provided a clear evidence of the subcellular distribution of PMMA NPs in living cells as well as of their ability to promote the MB internalization (Figure 4 ).
Conclusion
We have shown that oligonucleotide optical switches, together with NPs, can play a fundamental role in achieving quantitative information on intracellular events. The conducted analytical characterization has demonstrated that they can be used not only as simple on-off elements but also as real sensors.
